Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
• Immunoglobulin variable (V) genes and CD38 expression are prognostic markers in CLL.
• Zeta-associated protein 70 (ZAP-70) is a signaling molecule found in T cells and some B-cell malignancies.

Purpose of the Study:

• To investigate the expression of ZAP-70 in CLL B cells.
• To determine the correlation between ZAP-70 expression and immunoglobulin gene mutational status and CD38 expression.
• To explore the functional consequences of ZAP-70 expression on B-cell receptor (BCR) signaling.

Main Methods:

• Isolated leukemia B cells from CLL patients were analyzed for ZAP-70 protein expression.
• Immunoglobulin V gene mutational status and CD38 expression levels were assessed.
• B-cell receptor (BCR) complex ligation was performed, followed by analysis of tyrosine phosphorylation of cytosolic proteins and ZAP-70 association with signaling components.

Main Results:

• CLL B cells with nonmutated immunoglobulin V genes expressed high levels of ZAP-70, comparable to normal T cells.
• CLL B cells with mutated immunoglobulin V genes or low CD38 expression generally lacked detectable ZAP-70.
• ZAP-70 expression in CLL cells was associated with enhanced tyrosine phosphorylation of cytosolic proteins, including p72(Syk), upon BCR ligation.
• ZAP-70 was tyrosine phosphorylated and associated with surface immunoglobulin and CD79b following BCR ligation, indicating its role in BCR signaling.

Conclusions:

• ZAP-70 expression in CLL B cells is linked to nonmutated immunoglobulin receptors and enhanced BCR signal transduction.
• ZAP-70 may serve as a biomarker for a more aggressive clinical course in CLL.
• The study provides insights into the molecular mechanisms underlying CLL pathogenesis and progression.